Clinical Trial Update: Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update assessing the pharmacokinetics, pharmacodynamics, and safety of biphasic insulin aspart 30 in people with type 2 diabetes, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic insulin aspart 30 (insulin aspart, biphasic 30/70)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED